Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.5 HKD | -3.14% | +6.50% | -9.94% |
06:30am | Innovent Biologics, Inc. Appoints Samuel Zhang as Global Chief Business Officer | CI |
Apr. 17 | Innovent Appoints Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.94% | 8.24B | |
-3.45% | 87.17B | |
+1.97% | 40.1B | |
+57.67% | 25.12B | |
-14.82% | 15.59B | |
-8.82% | 12B | |
-16.29% | 11.8B | |
-41.58% | 11.8B | |
+7.19% | 8.81B | |
+0.95% | 7.62B |
- Stock Market
- Equities
- 1801 Stock
- News Innovent Biologics, Inc.
- Innovent Biologics : Drug Approved for Cancer Treatment